📣 VC round data is live. Check it out!

Icecure Medical Valuation Multiples

Discover revenue and EBITDA valuation multiples for Icecure Medical and similar public comparables like Lifeward, Co-Diagnostics, Geratherm Medical, Iridex and more.

Icecure Medical Overview

About Icecure Medical

Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.


Founded

2006

HQ

United States

Employees

66

Financials (LTM)

Revenue: $5M
Net Income: ($16M)

EV

$11M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Icecure Medical Financials

Icecure Medical reported last 12-month revenue of $5M.

In the same LTM period, Icecure Medical generated $2M in gross profit and had net loss of ($16M).

Revenue (LTM)


Icecure Medical P&L

In the most recent fiscal year, Icecure Medical reported revenue of $3M and EBITDA of ($15M).

Icecure Medical is unprofitable as of last fiscal year, with gross margin of 36%, EBITDA margin of (438%), and net margin of (446%).

See analyst estimates for Icecure Medical
LTMLast FY202320242025202620272028
Revenue$5M$3M$3M$3M$3M
Gross Profit$2M$1M$1M$1M$1M
Gross Margin42%36%40%44%36%
EBITDA($15M)($15M)($15M)($15M)
EBITDA Margin(438%)(472%)(467%)(438%)
EBIT Margin(345%)(447%)(482%)(477%)(447%)
Net Profit($16M)($15M)($15M)($15M)($15M)
Net Margin(343%)(446%)(454%)(465%)(446%)

Financial data powered by Morningstar, Inc.

Icecure Medical Stock Performance

Icecure Medical has current market cap of $19M, and enterprise value of $11M.

Market Cap Evolution


Icecure Medical's stock price is $0.23.

Icecure Medical share price decreased by 21.6% in the last 30 days, and by 77.2% in the last year.

Icecure Medical has an EPS (earnings per share) of $-0.19.

See more trading valuation data for Icecure Medical
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$11M$19M0.0%-21.6%-56.9%-77.2%$-0.19

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Icecure Medical Valuation Multiples

Icecure Medical trades at 2.4x EV/Revenue multiple, and (0.8x) EV/EBITDA.

See NTM and 2027E valuation multiples for Icecure Medical

EV / Revenue (LTM)


Icecure Medical Financial Valuation Multiples

As of May 26, 2026, Icecure Medical has market cap of $19M and EV of $11M.

Icecure Medical has a P/E ratio of (1.2x).

LTMLast FY202320242025202620272028
EV/Revenue2.4x3.3x3.4x3.4x3.3x
EV/EBITDA(0.8x)(0.7x)(0.7x)(0.8x)
EV/EBIT(0.7x)(0.7x)(0.7x)(0.7x)(0.7x)
EV/Gross Profit5.8x9.1x8.5x7.7x9.1x
P/E(1.2x)(1.3x)(1.3x)(1.2x)(1.3x)
EV/FCF(0.8x)(0.9x)(0.9x)(0.8x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Icecure Medical Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Icecure Medical Margins & Growth Rates

Icecure Medical grew revenue by 89% and net profit by 10% in the last fiscal year.

In the most recent fiscal year, Icecure Medical reported gross margin of 36%, EBITDA margin of (438%), and net margin of (446%).

See estimated margins and future growth rates for Icecure Medical

Icecure Medical Margins

Last FY202420252026202720282029
Gross Margin36%44%36%46%
EBITDA Margin(438%)(467%)(438%)
EBIT Margin(447%)(477%)(447%)(264%)
Net Margin(446%)(465%)(446%)(261%)
FCF Margin(432%)(384%)(432%)(119%)

Icecure Medical Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth89%2%3%89%
Gross Profit Growth140%12%(16%)140%
EBITDA Growth1%(4%)
EBIT Growth11%1%(4%)11%
Net Profit Growth10%5%(2%)10%
FCF Growth(48%)(3%)16%(48%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Icecure Medical Operational KPIs

Icecure Medical's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.2M for the same period.

Access forward-looking KPIs for Icecure Medical
LTMLast FY202320242025202620272028
Revenue per Employee$0.1M
Opex per Employee$0.2M
S&M Expenses to Revenue107%129%38%35%31%
G&A Expenses to Revenue104%232%229%271%232%
R&D Expenses to Revenue177%220%256%216%220%
Opex to Revenue483%523%521%483%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Icecure Medical Competitors

Icecure Medical competitors include Lifeward, Co-Diagnostics, Geratherm Medical, Iridex, Elbit Imaging, Cambridge Cognition, Scandinavian Real Heart, Inspira Technologies, Promimic and Labo Euromedis.

Most Icecure Medical public comparables operate across Medical Devices, DeepTech and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Lifeward0.8x0.7x(1.0x)
Co-Diagnostics19.9x19.9x(0.4x)
Geratherm Medical0.4x2.7x
Iridex0.4x0.4x9.5x14.0x
Elbit Imaging
Cambridge Cognition1.7x1.5x(31.1x)(88.9x)
Scandinavian Real Heart(4.1x)
Inspira Technologies0.7x(3.8x)

This data is available for Pro users. Sign up to see all Icecure Medical competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Icecure Medical

When was Icecure Medical founded?Icecure Medical was founded in 2006.
Where is Icecure Medical headquartered?Icecure Medical is headquartered in United States.
How many employees does Icecure Medical have?As of today, Icecure Medical has over 66 employees.
Who is the CEO of Icecure Medical?Icecure Medical's CEO is Eyal Shamir.
Is Icecure Medical publicly listed?Yes, Icecure Medical is a public company listed on Nasdaq.
What is the stock symbol of Icecure Medical?Icecure Medical trades under ICCM ticker.
When did Icecure Medical go public?Icecure Medical went public in 2013.
Who are competitors of Icecure Medical?Icecure Medical main competitors include Lifeward, Co-Diagnostics, Geratherm Medical, Iridex, Elbit Imaging, Cambridge Cognition, Scandinavian Real Heart, Inspira Technologies, Promimic, Labo Euromedis.
What is the current market cap of Icecure Medical?Icecure Medical's current market cap is $19M.
What is the current revenue of Icecure Medical?Icecure Medical's last 12 months revenue is $5M.
What is the current revenue growth of Icecure Medical?Icecure Medical revenue growth (NTM/LTM) is 93%.
What is the current EV/Revenue multiple of Icecure Medical?Current revenue multiple of Icecure Medical is 2.4x.
Is Icecure Medical profitable?No, Icecure Medical is not profitable.
What is the current net income of Icecure Medical?Icecure Medical's last 12 months net income is ($16M).
How many companies Icecure Medical has acquired to date?Icecure Medical hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Icecure Medical has invested to date?Icecure Medical hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Icecure Medical

Lists including Icecure Medical

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial